Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Ketolides Market Grown from 2024 to 2025?

The size of the ketolides market has been witnessing a consistent increase over the past few years and is expected to expand from $3.22 billion in 2024 to $3.35 billion in 2025, with a compound annual growth rate (CAGR) of 4.1%. The growth observed in the historic stage may be credited to the rising occurrence of infectious diseases, enhanced antibiotic use, the demand for efficient and easy treatment options for infectious diseases, and initiatives taken by the government.

What Growth Rate Is Anticipated for the Ketolides Market in the Coming Years?

In the coming years, a steady expansion is anticipated in the ketolides market. The market is predicted to increase to a value of $4.04 billion by the year 2029, exhibiting a compound annual growth rate (CAGR) of 4.8%. The predicted growth within the forecast period is largely due to investment in research and development for ketolides, an increase in screenings for infectious diseases, incremental growth in healthcare expenditure, and a heightened awareness regarding antimicrobial stewardship. The forecast period is likely to see major trends such as innovative infectious disease treatments, targeted therapy developments, advancements in diagnosis and treatment methods for infectious diseases, and the production of new ketolide formulations.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12918&type=smp

Who Are the Leading Companies in the Ketolides Market?

Major companies operating in the ketolides market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories, GSK PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Daiichi Sankyo Company Limited, Shionogi & Company Limited, Dr. Reddys Laboratories Ltd., Taisho Pharmaceutical Co. Ltd., Glenmark Pharmaceuticals Ltd., Zhejiang Yongtai Technology Co. Ltd., Corden Pharma GmbH, Optimer Pharmaceuticals Inc., Vivimed Labs Limited, Wockhardt Ltd., Advanced Life Sciences Holdings Inc.

What Are the Key Drivers of the Ketolides Market?

The rise in infectious diseases is anticipated to boost the ketolides market’s expansion. Such diseases are caused by pathogens — bacteria, viruses, fungi, or parasites — and exhibit a wide variety of symptoms. They can be transmitted from one individual to another. Tuberculosis is a case in point. Ketolides have shown potential for treating tuberculosis because they exhibit high intracellular activities, critical for battling the disease. According to data released by the government department GOV.UK in February 2024, tuberculosis cases in England increased by 10.7% in 2023, from 4,380 in 2022 to 4,850. Consequently, the surge in infectious diseases is propelling the ketolides market growth.

Ketolides Market Driver: Rising Chronic Sinusitis Cases Propel Ketolides Market Growth

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=12918&type=smp

What Are the Key Market Segments in the Ketolides Industry?

The ketolides market covered in this report is segmented –

1) By Drug Type: Telithromycin, Cethromycin, Solithromycin

2) By Indication: Bronchitis, Pneumonia, Sinusitis, Tonsillitis Or Pharyngitis

3) By Microorganism: Streptococcus Pneumoniae, Haemophilus Influenzae, Moraxella Catarrhalis, Chlamydophila Pneumoniae, Mycoplasma Pneumoniae

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels

What Are the Latest Trends in the Ketolides Market?

Leading firms in the ketolides market are concentrating on the development of novel drugs and therapies to maintain their competitive edge and retain their market presence. For example, in June 2023, AliquantumRx Inc., a biotechnical research firm based in the US, received approval from the United States Patent and Trademark Office (USPTO), a Department of Commerce agency, for its patent ‘salts and polymorphs of cethromycin for treating bacterial and protozoan diseases.’ Cethromycin, a ketolide antibiotic variety, is potent in treating various infections caused by bacteria and protozoa, including malaria, babesiosis, toxoplasmosis, diarrhea, among others. This fresh patent allows the company to broaden its reach and reduces the commercialization risk of cethromycin by permitting its use for diseases other than malaria.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/ketolides-global-market-report

What Are the Key Regional Markets in the Ketolides Industry?

North America was the largest region in the ketolides market in 2024. The regions covered in ketolides market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12918

This Report Delivers Insight On:

1. How big is the ketolides market, and how is it changing globally?

2. Who are the major companies in the ketolides market, and how are they performing?

3. What are the key opportunities and risks in the ketolides market right now?

4. Which products or customer segments are growing the most in the ketolides market?

5. What factors are helping or slowing down the growth of the ketolides market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model